AB0005 Hla class ii in paraguayan immune-mediated inflammatory patients

BackgroundImmune-mediated inflammatory disease (IMID) is a concept used to describe a group of conditions that share common inflammatory pathways leading to systemic inflammation. The best-known genetic factor for IMID susceptibility is the human leukocyte antigen (HLA) haplotypes. Nowadays, there i...

Full description

Saved in:
Bibliographic Details
Published inAnnals of the rheumatic diseases Vol. 77; no. Suppl 2; p. 1207
Main Authors Acosta-Colman, I., Cabrera-Villalba, S., Avila-Pedretti, G., Acosta Hetter, M.E., Vazquez, M., Ayala Lugo, A., Jolie, V., Roman, L., Melo, M., González, M., Duarte, M., Torio, H., Martínez de Filártiga, M.T.
Format Journal Article
LanguageEnglish
Published London BMJ Publishing Group LTD 01.06.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:BackgroundImmune-mediated inflammatory disease (IMID) is a concept used to describe a group of conditions that share common inflammatory pathways leading to systemic inflammation. The best-known genetic factor for IMID susceptibility is the human leukocyte antigen (HLA) haplotypes. Nowadays, there is a lack of information about HLA profile in Paraguayan patients with IMIDs.ObjectivesTo identify HLA alleles associated with susceptibility to develop an IMID in Paraguayan patients controlled in a reference centre.MethodsParaguayan IMID patients were recruited from the Rheumatology Department of Hospital de Clínicas, Paraguay. IMID HLA II frequencies where compared with a control group of 50 unrelated individuals without disease and from the same geographic origin. Genotyping for HLA was performed using Luminex PCR technology. The association analysis with the IMIDs risk was performed using the chi-square allelic test.Results249 IMID patients (95 lupus,104 rheumatoid arthritis and 50 systemic sclerosis) where included. Of these 84,4% were women with an average age of 43,4 (±14). Comparing the haplotypes profiles for the 5 HLA class II genes between the patients and the healthy controls, in the risk association analysis, the association of the known risk allele was corroborated HLADRB1*03:01 (p=2e-06, OR:14,97). A significant association was identified between the allele HLADRB1* 08:02 (p=0.0271, OR:0,13) and HLADRB1* 08:07 (p=0.0133, OR: 0.08). In the gene HLADQA1, 1 allele associated with the IMIDs were found, the HLADQA1*04:01 (p=1.4e-05, OR: 0.06). In the HLADPB1 gene 3 alleles associated with the IMIDs were identified: HLADPB1*02:01 (p=4.2e-05, OR: 82.91), HLADPB1*03:01 (p=2e-06, OR: 14.97), HLADPB1*04:01 (p=1.5e-05 OR: 34.55). Different associations between IMIDs and alleles was identify (table 1).Abstract AB0005 – Table 1List of associated alleles stratified by diseaseALLELE (Systemic Lupus Erythematosus Cohort)P-valourOR HLADQA1*02:010.025314ALLELES (Rheumatoid Arthritis Cohort)P-valourORHLADRB1*08:020.03670.11HLADPB1*02:010.000354.62HLADPB1*03:010.00107.92HLADPB1*04:010.000129.69HLADQA1*02:010.04670.24HLADQA1*04:010.0020.07HLADPA1*02:010.00220.029ALLELES (Scleroderma Cohort)P-valourORHLADPB1*02:010.000382.33HLADPB1*03:010.00948.44HLADPB1*04:010.000147.50HLADQA1*04:010.00130.06ConclusionsIn the genetic association analysis, already known associations have been replicated and new ones previously unpublished have been identified in Paraguayan IMIDs patients. This is the first genetic association study in IMID patients Paraguayan origin.Disclosure of InterestNone declared
ISSN:0003-4967
1468-2060
DOI:10.1136/annrheumdis-2018-eular.5021